Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | DNLI |
---|---|---|
09:32 ET | 7266 | 22.6 |
09:34 ET | 300 | 22.9 |
09:36 ET | 1380 | 22.96 |
09:38 ET | 3000 | 22.91 |
09:39 ET | 515 | 22.975 |
09:41 ET | 400 | 23.03 |
09:43 ET | 1160 | 22.98 |
09:45 ET | 3134 | 23 |
09:48 ET | 300 | 22.975 |
09:50 ET | 1100 | 22.92 |
09:52 ET | 500 | 22.885 |
09:54 ET | 15399 | 22.815 |
09:56 ET | 200 | 22.87 |
09:57 ET | 700 | 22.845 |
09:59 ET | 13560 | 22.5765 |
10:01 ET | 518 | 22.56 |
10:03 ET | 900 | 22.52 |
10:06 ET | 800 | 22.47 |
10:08 ET | 342 | 22.47 |
10:10 ET | 607 | 22.5175 |
10:12 ET | 1000 | 22.6 |
10:14 ET | 1612 | 22.595 |
10:15 ET | 390 | 22.615 |
10:17 ET | 2233 | 22.49 |
10:19 ET | 112 | 22.48 |
10:21 ET | 1090 | 22.46 |
10:24 ET | 900 | 22.46 |
10:26 ET | 500 | 22.5 |
10:28 ET | 900 | 22.48 |
10:30 ET | 900 | 22.435 |
10:32 ET | 2032 | 22.53 |
10:33 ET | 900 | 22.455 |
10:35 ET | 4000 | 22.4831 |
10:37 ET | 1200 | 22.41 |
10:39 ET | 1000 | 22.41 |
10:42 ET | 127 | 22.43 |
10:44 ET | 200 | 22.47 |
10:46 ET | 640 | 22.52 |
10:48 ET | 500 | 22.5 |
10:50 ET | 890 | 22.51 |
10:51 ET | 400 | 22.5 |
10:53 ET | 400 | 22.49 |
10:55 ET | 514 | 22.46 |
10:57 ET | 3378 | 22.465 |
11:00 ET | 800 | 22.41 |
11:02 ET | 600 | 22.36 |
11:04 ET | 1100 | 22.29 |
11:06 ET | 600 | 22.24 |
11:08 ET | 524 | 22.23 |
11:09 ET | 668 | 22.19 |
11:11 ET | 2643 | 22.1 |
11:13 ET | 100 | 22.1 |
11:15 ET | 756 | 22.09 |
11:18 ET | 1601 | 22.11 |
11:20 ET | 1400 | 22.12 |
11:22 ET | 700 | 22.18 |
11:24 ET | 811 | 22.17 |
11:26 ET | 3102 | 22.27 |
11:27 ET | 2618 | 22.25 |
11:29 ET | 100 | 22.3 |
11:31 ET | 655 | 22.21 |
11:33 ET | 600 | 22.19 |
11:36 ET | 612 | 22.23 |
11:38 ET | 100 | 22.19 |
11:40 ET | 460 | 22.15 |
11:42 ET | 1571 | 22.095 |
11:44 ET | 925 | 21.97 |
11:45 ET | 3240 | 22.03 |
11:47 ET | 3365 | 22.08 |
11:49 ET | 4136 | 22.2 |
11:51 ET | 2257 | 22.275 |
11:54 ET | 6143 | 22.29 |
11:56 ET | 200 | 22.355 |
11:58 ET | 500 | 22.39 |
12:00 ET | 100 | 22.455 |
12:02 ET | 787 | 22.51 |
12:03 ET | 856 | 22.5534 |
12:05 ET | 600 | 22.53 |
12:07 ET | 300 | 22.53 |
12:09 ET | 1500 | 22.495 |
12:12 ET | 5322 | 22.48 |
12:14 ET | 600 | 22.49 |
12:16 ET | 830 | 22.51 |
12:18 ET | 4313 | 22.49 |
12:20 ET | 700 | 22.52 |
12:21 ET | 625 | 22.525 |
12:23 ET | 544 | 22.58 |
12:25 ET | 100 | 22.59 |
12:27 ET | 341 | 22.59 |
12:30 ET | 804 | 22.65 |
12:32 ET | 400 | 22.66 |
12:34 ET | 200 | 22.645 |
12:36 ET | 1622 | 22.53 |
12:41 ET | 500 | 22.47 |
12:45 ET | 300 | 22.48 |
12:48 ET | 200 | 22.49 |
12:50 ET | 300 | 22.48 |
12:52 ET | 300 | 22.495 |
12:54 ET | 300 | 22.48 |
12:57 ET | 500 | 22.5 |
12:59 ET | 100 | 22.51 |
01:03 ET | 1700 | 22.48 |
01:06 ET | 100 | 22.47 |
01:08 ET | 100 | 22.51 |
01:10 ET | 200 | 22.505 |
01:12 ET | 766 | 22.54 |
01:14 ET | 1500 | 22.56 |
01:15 ET | 300 | 22.5725 |
01:17 ET | 2036 | 22.62 |
01:19 ET | 400 | 22.63 |
01:21 ET | 2435 | 22.65 |
01:24 ET | 800 | 22.65 |
01:26 ET | 1167 | 22.64 |
01:28 ET | 500 | 22.62 |
01:30 ET | 1200 | 22.57 |
01:32 ET | 1100 | 22.54 |
01:33 ET | 1300 | 22.49 |
01:35 ET | 1090 | 22.45 |
01:37 ET | 2177 | 22.46 |
01:39 ET | 3580 | 22.54 |
01:42 ET | 1038 | 22.57 |
01:44 ET | 500 | 22.61 |
01:46 ET | 250 | 22.62 |
01:48 ET | 1737 | 22.72 |
01:50 ET | 6018 | 22.8 |
01:51 ET | 5477 | 22.8 |
01:53 ET | 5438 | 22.83 |
01:55 ET | 2641 | 22.82 |
01:57 ET | 400 | 22.83 |
02:00 ET | 2866 | 22.86 |
02:02 ET | 2600 | 22.83 |
02:04 ET | 1427 | 22.84 |
02:06 ET | 4179 | 22.86 |
02:08 ET | 6863 | 22.91 |
02:09 ET | 4434 | 22.955 |
02:11 ET | 2140 | 22.98 |
02:13 ET | 1826 | 23.02 |
02:15 ET | 600 | 23.08 |
02:18 ET | 2737 | 23.105 |
02:20 ET | 1400 | 23.19 |
02:22 ET | 2700 | 23.19 |
02:24 ET | 3130 | 23.19 |
02:26 ET | 1333 | 23.2 |
02:27 ET | 2559 | 23.23 |
02:29 ET | 2267 | 23.13 |
02:31 ET | 1447 | 23.1 |
02:33 ET | 864 | 23.1 |
02:36 ET | 400 | 23.09 |
02:38 ET | 7125 | 23.16 |
02:40 ET | 3769 | 23.155 |
02:42 ET | 4304 | 23.18 |
02:44 ET | 4329 | 23.21 |
02:45 ET | 6639 | 23.04 |
02:47 ET | 21978 | 23 |
02:49 ET | 2282 | 22.935 |
02:51 ET | 600 | 22.97 |
02:54 ET | 1300 | 22.95 |
02:56 ET | 3878 | 22.995 |
02:58 ET | 8268 | 22.99 |
03:00 ET | 2579 | 23.01 |
03:02 ET | 2111 | 22.985 |
03:03 ET | 4222 | 23.01 |
03:05 ET | 1600 | 23.005 |
03:07 ET | 29747 | 23.045 |
03:09 ET | 1907 | 23.045 |
03:12 ET | 7981 | 23.2 |
03:14 ET | 3628 | 23.29 |
03:16 ET | 3408 | 23.28 |
03:18 ET | 1400 | 23.21 |
03:20 ET | 2209 | 23.18 |
03:21 ET | 8498 | 23.19 |
03:23 ET | 2802 | 23.15 |
03:25 ET | 627 | 23.125 |
03:27 ET | 3502 | 23.175 |
03:30 ET | 4349 | 23.15 |
03:32 ET | 3826 | 23.055 |
03:34 ET | 5149 | 23.085 |
03:36 ET | 1656 | 23.115 |
03:38 ET | 400 | 23.13 |
03:39 ET | 2401 | 23.11 |
03:41 ET | 1615 | 23.09 |
03:43 ET | 1714 | 23.08 |
03:45 ET | 4100 | 23.07 |
03:48 ET | 3941 | 23.08 |
03:50 ET | 3353 | 23.02 |
03:52 ET | 18901 | 23.15 |
03:54 ET | 9542 | 23.17 |
03:56 ET | 27609 | 23.315 |
03:57 ET | 17822 | 23.28 |
03:59 ET | 21384 | 23.22 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Denali Therapeutics Inc | 3.3B | -24.0x | --- |
Arrowhead Pharmaceuticals Inc | 3.2B | -6.1x | --- |
MorphoSys AG | 2.7B | -5.4x | --- |
Amicus Therapeutics Inc | 2.9B | -20.1x | --- |
Axsome Therapeutics Inc | 3.8B | -12.6x | --- |
Genmab A/S | 16.6B | 21.1x | +22.71% |
Denali Therapeutics Inc. is a biopharmaceutical company. The Company is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company has a portfolio of both small molecule and biotherapeutic medicines, comprising seven product candidates in clinical development across seven indications as well as preclinical therapeutic candidates. Its three late-stage development programs include tividenofusp alfa (DNL310) for mucopolysaccharidosis II (MPS II); BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease; and DNL343 (eIF2B activator) for amyotrophic lateral sclerosis (ALS). SAR443820/DNL788 (RIPK1 inhibitor) is being evaluated in a Phase II study for multiple sclerosis (MS). In addition, it has a Phase I/II study of TAK-594/DNL593 for frontotemporal dementia-granulin (FTD-GRN) and a Phase I/II study of DNL126 for MPS IIIA (Sanfilippo syndrome).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.3B |
---|---|
Revenue (TTM) | $295.4M |
Shares Outstanding | 142.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.40 |
EPS | $-0.97 |
Book Value | $7.45 |
P/E Ratio | -24.0x |
Price/Sales (TTM) | 11.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -65.54% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.